281 followers
RT @FrontImmunol: New Research: Cost-effectiveness analysis of toripalimab plus chemotherapy versus chemotherapy alone for advanced non-smaโฆ
RT @FrontImmunol: New Research: Cost-effectiveness analysis of toripalimab plus chemotherapy versus chemotherapy alone for advanced non-smaโฆ
New Research: Cost-effectiveness analysis of toripalimab plus chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer in China: Background Toripalimab is the first domestic anti-tumor programmed death 1 antibodyโฆ #immunology https:/